Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS)
Clinical trial NCT03303066 · COMPLETED
Trial details
- NCT number
- NCT03303066
- Sponsor
- Kyntra Bio
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-06
- Primary completion
- 2023-01-11
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.